Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2003
09/30/2003US6627194 Activated immunoglobulin
09/30/2003US6627187 Containing an amino acid as a stabilizer; long term storage stability
09/30/2003US6627088 Depth-type filter for killing microorganisms and inactivating viruses and its use
09/30/2003US6626669 Oral therapeutic delivery appliance
09/30/2003US6626329 Platen pump
09/30/2003CA2300054C Foam skin cream, uses of the foam skin protection cream and a process for its preparation
09/30/2003CA2149152C Pulsatile particles drug delivery system
09/30/2003CA2141582C Pelletised pharmaceutical composition
09/30/2003CA2108788C Liposomal prostaglandin formulations
09/30/2003CA2099585C Pharmaceutical compositions
09/30/2003CA2041579C Dosage form
09/29/2003CA2423915A1 Process for producing nanoparticles of paclitaxel and albumin
09/29/2003CA2423884A1 Improved paclitaxel-based antitumor formulation
09/25/2003WO2003078874A2 Coated microfluidic delivery system
09/25/2003WO2003078579A2 Compositions and methods for treating emphysema
09/25/2003WO2003078508A1 Polymer composite with internally distributed deposition matter
09/25/2003WO2003078500A1 Polyalkylene graft polymers
09/25/2003WO2003078489A1 Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
09/25/2003WO2003078429A1 Micronized crystalline tiotropium bromide
09/25/2003WO2003078408A1 Crystalline parecoxib sodium
09/25/2003WO2003078387A1 Formulations of anthraquinone derivatives
09/25/2003WO2003078383A1 Novel positively charged lipids and liposomes comprising the positively charged lipids
09/25/2003WO2003078049A1 Vesicles comprising an amphiphilic di-block copolymer and a hydrophobic compound.
09/25/2003WO2003077972A2 Implantable drug delivery system
09/25/2003WO2003077965A1 Polymer composition loaded with cells
09/25/2003WO2003077964A1 Absorbent hydrogels
09/25/2003WO2003077952A1 Topical composition comprising a cyclofructan, a carrier and a drug
09/25/2003WO2003077951A1 Percutaneous absorption promoters and compositions for treating athlete’s foot
09/25/2003WO2003077944A1 Improvements in vaccination
09/25/2003WO2003077943A2 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound
09/25/2003WO2003077940A1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases
09/25/2003WO2003077937A1 Pharmaceutical compositions comprising mannose binding lectin
09/25/2003WO2003077929A1 Fosinopril formulation
09/25/2003WO2003077927A1 Sulfatase inhibiting progestogen-only contraceptive regimens
09/25/2003WO2003077926A1 Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
09/25/2003WO2003077925A1 Sulfatase inhibiting continuous progestogen contraceptive regimens
09/25/2003WO2003077924A1 Continuous sulfatase inhibiting progestogen hormone replacement therapy
09/25/2003WO2003077923A1 Progesterone oral drug delivery system
09/25/2003WO2003077922A1 Composition in an aqueous gel state, method for the production and use thereof in the production of a medicament, in particular an antiherpetic medicament
09/25/2003WO2003077920A1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo’1,5-bipyridazine in nanoparticulate form
09/25/2003WO2003077905A1 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophtalmic topical use capable of improving the level of l-ascorbic acid in the eye
09/25/2003WO2003077891A1 Powdery medicinal compositions for inhalation and process for producing the same
09/25/2003WO2003077890A1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
09/25/2003WO2003077889A1 Implantable device with invasive and non-invasive reversible infusion rate adjustability
09/25/2003WO2003077888A2 Compressed tablets comprising microcapsules with modified release
09/25/2003WO2003077887A1 Microparticles and method for their production
09/25/2003WO2003077886A1 Method of manufacturing chemical-containing composite particles
09/25/2003WO2003077885A2 Free-base formulations of local anesthetics
09/25/2003WO2003077883A2 Composition and utilization thereof for forming a protective film on nasal mucous membranes
09/25/2003WO2003077882A2 Preparation of sterile stabilized nanodispersions
09/25/2003WO2003077867A2 Naltrexone hydrochloride compositions
09/25/2003WO2003077861A2 Water-based delivery systems
09/25/2003WO2003077846A2 New therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
09/25/2003WO2003077845A2 Compositions and methods for treating glaucoma and ocular hypertension
09/25/2003WO2003077842A2 Palatable oral suspension and method
09/25/2003WO2003077834A2 Central airway administration for systemic delivery of therapeutics
09/25/2003WO2003077827A1 Process for producing drug solid dispersion
09/25/2003WO2003077825A2 Site specific delivery of co-administered drugs via inhalation
09/25/2003WO2003077811A1 Pharmaceutically active compounds containing phosphorous defficient oil
09/25/2003WO2003077796A2 Ophthalmic solutions for delivery of expression vectors
09/25/2003WO2003077723A2 Methods and devices for detection and therapy of atheromatous plaque
09/25/2003WO2003070738A3 Topiramate salts and compositions comprising and methods of making and using the same
09/25/2003WO2003061568A3 Methods and therapeutic compositions in the treatment of advanced cancer
09/25/2003WO2003047552A3 Pharmaceutical composition comprising a 5ht1 receptor agonist
09/25/2003WO2003047494A3 Reverse micelle compositions and uses thereof
09/25/2003WO2003039472A3 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
09/25/2003WO2003032947A3 A method for preparing liposome formulations with a predefined release profile
09/25/2003WO2003026555A3 Floating osmotic device for controlled release drug delivery
09/25/2003WO2003020219A3 Aerosolized decongestants for the treatment of sinusitis
09/25/2003WO2003018064A3 Lipophilic drug compositions
09/25/2003WO2003015690A3 Method for treating primary insomnia
09/25/2003WO2003011249A3 Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome
09/25/2003WO2003006993A3 Gel compositions
09/25/2003WO2002100436A3 Ophthalmic once-a-day composition
09/25/2003WO2002100412A3 Stabilized dispersion of phytosterol in oil
09/25/2003WO2002098339A3 Zinc containing compositions for anti-viral use
09/25/2003WO2002094282A3 Compositions with methylprednisolone derivatives having therapeutic effect
09/25/2003WO2002085300A3 Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
09/25/2003WO2002062368A3 Method of inducing a ctl response
09/25/2003WO2002055061A3 Method of producing porous tablets with improved dissolution properties
09/25/2003WO2002017855A3 Process for preparing pharmaceutical compositions for use with soft gelatin formulations
09/25/2003US20030181889 Provides nutrients/growth factors to begin the regeneration and growth of connective tissues/ligaments/tendons
09/25/2003US20030181888 Infusion pump with access regulator
09/25/2003US20030181852 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
09/25/2003US20030181851 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
09/25/2003US20030181847 For topical treatment of nail diseases (onychomycosis) after forming aperture in infected nail with laser beam; fungicides (terbinafine)
09/25/2003US20030181662 Human procalcitonin and the preparation and use thereof
09/25/2003US20030181613 Mixing solutions containing addition monomers, macromolecular biodegradable chain-transfer agents and activators, then degassing with inert gases and polymerizing to form addition-condensation copolymers used as micelles for drug delivery
09/25/2003US20030181530 Soluble compositions of triphenylethylene antiestrogens
09/25/2003US20030181527 Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone
09/25/2003US20030181524 Stabilized, non-granulated, immediate release
09/25/2003US20030181516 Substance with sedative effect
09/25/2003US20030181515 Administering to a subject in need of pain relief a medicinal ointment comprising an active kavalactone selected from the group consisting of dihydrokawain, dihydromethysticin, kawain and medicinally acceptable carrier
09/25/2003US20030181512 For therapy and prophylaxis of obesity and hyperlipidemia; side effect reduction
09/25/2003US20030181508 For therapy of attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder
09/25/2003US20030181501 Therapy and prophylaxis of cyclooxygenase-2 mediated conditions and disorders
09/25/2003US20030181478 A liquid, propellant-free mixtures for treating asthma or chronic obstructive pulmonary disease; tiotropium bromide
09/25/2003US20030181475 Method of administering buprenorphine to treat depression
09/25/2003US20030181451 Use of triazinetrione sulfoxides for controlling coccidioses
09/25/2003US20030181439 Use of paullone derivatives for making medicines
1 ... 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 ... 2991